|Day Low/High||75.32 / 77.44|
|52 Wk Low/High||65.25 / 92.64|
I continue to see these names as bargains in the biotech and biopharma space.
Tech and retail gains aren't enough to lead markets to new highs.
Options spreads aren't tradable with some small biotechs, making shares the only way to play.
These names are moving up or down in a big way ahead of releasing drug-trial results.
After a strong week for the biotech sector, these names have potential catalysts to move shares.
Let's take a look at the charts and indicators to see what may lie ahead for this drug maker.
I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.
Data and industry conferences will likely be catalysts for shares in the space.
Watch for these upstart names to topple some big-caps going forward.
Let's review the charts and indicators to see where this move may carry in the weeks ahead.
When the broad market rallies and your stock does not participate there is a message there and that bothers me.
There is nothing wrong with Intel, Johnson & Johnson, 3M and Apple.
Economic conditions seem to be improving for laborers. Perhaps rapidly.
This Black History month, we are taking a look at the African Americans who have made it to the C-Suite and are making a difference. And sadly, there are not many. Watch our video to learn the names you should know now.
It's time again to visit with the latest charts and indicators.
They make more irrational, stupid moves based on nothing than I ever thought possible.
It might look easy now, but it looked easy in 1999, too.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending topics.
Consider that MRK analysts are projecting earnings growth this year and next.
A rundown of the five worst performing stocks in the Dow Industrials.
We have seen this pattern many times in the last few months, and it is a surreal pattern for traders.
The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.
* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...